Zifo Launches AI-Powered Antibody Engineering App on Snowflake Marketplace for Biologics and Drug Discovery
ByAinvest
Thursday, Aug 14, 2025 8:38 am ET1min read
SNOW--
The Antibody Engineering app integrates state-of-the-art AI models, such as ProtGPT2, ESM, and RoBERTa, into a seamless workflow. Users can fine-tune these models on their proprietary datasets within Snowflake's secure environment, generating novel antibody sequences and predicting their 3D structures. This end-to-end solution aims to improve the hit rate for high-affinity therapeutic antibodies, a significant challenge in traditional drug development.
Chris McClure, Head of Solution Services for Zifo in North America, stated, "We are entering a new era of drug discovery, one where AI and data converge to solve biology's most complex puzzles. Zifo Antibody Engineering is more than just a tool; it's a strategic partner for scientists."
The platform's value extends across the life sciences ecosystem, offering biopharma R&D teams, CDMOs, CROs, academic institutions, and clinical and preclinical development teams the ability to leverage advanced protein modeling tools. The architecture is designed for high-performance AI workloads, handling massive datasets and multi-modal inputs with ease.
Zifo's Antibody Engineering App can be downloaded from the Snowflake Marketplace. For more information, visit [Zifo Technologies](https://www.zifornd.com).
References:
[1] https://www.prnewswire.com/news-releases/zifo-launches-ai-antibody-engineering-app-on-snowflake-marketplace-to-accelerate-biologics-and-drug-discovery-302530069.html
[2] https://blockchain.news/flashnews/deeplearning-ai-launches-fast-prototyping-of-genai-apps-with-streamlit-in-partnership-with-snowflake-snow-course-now-live
Zifo has launched an AI-powered antibody engineering app on Snowflake Marketplace, enabling biopharma companies and research institutions to design and optimize therapeutic antibodies faster. The cloud-native GenAI platform, built on Snowflake Data Cloud, integrates state-of-the-art AI into an end-to-end workflow, improving the hit rate for high-affinity therapeutic antibodies. By leveraging Snowflake's platform, users can fine-tune powerful protein language models without moving sensitive information outside of their secure environment.
Zifo Technologies has announced the launch of its AI-powered Antibody Engineering application on the Snowflake Marketplace. This cloud-native GenAI platform is designed to accelerate the development of therapeutic antibodies, promising to streamline the drug discovery process and reduce costs. The platform is built on Snowflake Data Cloud, offering a secure and scalable environment for biopharma companies, research institutions, and contract research organizations to design and optimize antibodies.The Antibody Engineering app integrates state-of-the-art AI models, such as ProtGPT2, ESM, and RoBERTa, into a seamless workflow. Users can fine-tune these models on their proprietary datasets within Snowflake's secure environment, generating novel antibody sequences and predicting their 3D structures. This end-to-end solution aims to improve the hit rate for high-affinity therapeutic antibodies, a significant challenge in traditional drug development.
Chris McClure, Head of Solution Services for Zifo in North America, stated, "We are entering a new era of drug discovery, one where AI and data converge to solve biology's most complex puzzles. Zifo Antibody Engineering is more than just a tool; it's a strategic partner for scientists."
The platform's value extends across the life sciences ecosystem, offering biopharma R&D teams, CDMOs, CROs, academic institutions, and clinical and preclinical development teams the ability to leverage advanced protein modeling tools. The architecture is designed for high-performance AI workloads, handling massive datasets and multi-modal inputs with ease.
Zifo's Antibody Engineering App can be downloaded from the Snowflake Marketplace. For more information, visit [Zifo Technologies](https://www.zifornd.com).
References:
[1] https://www.prnewswire.com/news-releases/zifo-launches-ai-antibody-engineering-app-on-snowflake-marketplace-to-accelerate-biologics-and-drug-discovery-302530069.html
[2] https://blockchain.news/flashnews/deeplearning-ai-launches-fast-prototyping-of-genai-apps-with-streamlit-in-partnership-with-snowflake-snow-course-now-live
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet